|
|
| Line 1: |
Line 1: |
| [[Image:1s5d.jpg|left|200px]] | | {{Seed}} |
| | [[Image:1s5d.png|left|200px]] |
|
| |
|
| <!-- | | <!-- |
| Line 9: |
Line 10: |
| {{STRUCTURE_1s5d| PDB=1s5d | SCENE= }} | | {{STRUCTURE_1s5d| PDB=1s5d | SCENE= }} |
|
| |
|
| '''Cholera holotoxin with an A-subunit Y30S mutation, Crystal form 2'''
| | ===Cholera holotoxin with an A-subunit Y30S mutation, Crystal form 2=== |
|
| |
|
|
| |
|
| ==Overview==
| | <!-- |
| Cholera toxin (CT) is a heterohexameric bacterial protein toxin belonging to a larger family of A/B ADP-ribosylating toxins. Each of these toxins undergoes limited proteolysis and/or disulfide bond reduction to form the enzymatically active toxic fragment. Nicking and reduction render both CT and the closely related heat-labile enterotoxin from Escherichia coli (LT) unstable in solution, thus far preventing a full structural understanding of the conformational changes resulting from toxin activation. We present the first structural glimpse of an active CT in structures from three crystal forms of a single-site A-subunit CT variant, Y30S, which requires no activational modifications for full activity. We also redetermined the structure of the wild-type, proenzyme CT from two crystal forms, both of which exhibit (i) better geometry and (ii) a different A2 "tail" conformation than the previously determined structure [Zhang et al. (1995) J. Mol. Biol. 251, 563-573]. Differences between wild-type CT and active CTY30S are observed in A-subunit loop regions that had been previously implicated in activation by analysis of the structure of an LT A-subunit R7K variant [van den Akker et al. (1995) Biochemistry 34, 10996-11004]. The 25-36 activation loop is disordered in CTY30S, while the 47-56 active site loop displays varying degrees of order in the three CTY30S structures, suggesting that disorder in the activation loop predisposes the active site loop to a greater degree of flexibility than that found in unactivated wild-type CT. On the basis of these six new views of the CT holotoxin, we propose a model for how the activational modifications experienced by wild-type CT are communicated to the active site.
| | The line below this paragraph, {{ABSTRACT_PUBMED_15049684}}, adds the Publication Abstract to the page |
| | (as it appears on PubMed at http://www.pubmed.gov), where 15049684 is the PubMed ID number. |
| | --> |
| | {{ABSTRACT_PUBMED_15049684}} |
|
| |
|
| ==About this Structure== | | ==About this Structure== |
| Line 31: |
Line 35: |
| [[Category: Cholera toxin]] | | [[Category: Cholera toxin]] |
| [[Category: Heat-labile enterotoxin]] | | [[Category: Heat-labile enterotoxin]] |
| ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 08:19:18 2008'' | | |
| | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 20:56:31 2008'' |